Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
General Internal Medicine
•
Psychiatry
•
Behavioral Neurology & Neuropsychiatry
•
Public & Community Psychiatry
How do you manage psychosis in a patient with Tardive Dyskinesia where clozapine is not an option?
e.g. patient refusal or contraindication
Related Questions
How do you manage sleep disturbances in patients with Alzheimer’s disease without relying heavily on deliriogenic medications?
What approaches have you found most helpful for concurrent severe major depressive disorder and alcohol use disorder?
How do you approach titration or transitioning to Cobenfy in patients currently on an antipsychotic?
How do you transition patients between different long-acting injectable antipsychotics?
How do stroke-risk considerations affect your use of atypical antipsychotics for patients with dementia?
How do you approach patients who identify so strongly with being sick or with a particular diagnostic label that it makes up a significant portion of their identity?
What strategies do you find most effective at managing opioid withdrawal in hospitalized patients who are not interested in MAT?
What strategies have you found effective in reducing intake no-show rates among patients with severe and persistent mental illness?
What strategies have you found effective for obtaining insurance approval for xanomeline-tropsium (Cobenfy)?
When do you consider pharmacogenetic testing to assist in the selection of antipsychotic medications?